Indeed, our data show that RAD18 recruitment to chromatin upon HU treatment depends on RFN168 in BRCA1-deficient cancer cells, indicating that RNF168 might act upstream of RAD18 to facilitate its recruitment to degraded forks and fork recovery. The gene discussed is BRCA1; the disease is cancer.